The study met its primary endpoint, demonstrating a highly statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to chemotherapy
New test expands access to early Alzheimer’s assessment, streamlining diagnostic pathways and improving referral efficiency
mRNA-4359 advances to phase 2 following encouraging results in checkpoint inhibitor-resistant Melanoma
The new data highlight the potential of AstraZeneca’s innovative therapies to improve outcomes across multiple cancer types
Cadila Pharmaceuticals has introduced Dlorfast-M-Tablets as a dual-action therapy that targets two key pathways of allergic response
The company will present new data from across over 20 cancer types and multiple treatment settings at European Society for Medical Oncology Congress 2025
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market
Subscribe To Our Newsletter & Stay Updated
